Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.378
Delayed Data
As of Sep 25
 -0.002 / -0.53%
Today’s Change
0.22
Today|||52-Week Range
0.40
+3.56%
Year-to-Date
ENZN Special Dividend: ENZN will begin trading ex-dividend on 09/29/17 with a $0.15 special dividend payable to shareholders of record as of 08/30/17.
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close0.38
Today’s open0.38
Day’s range0.38 - 0.39
Volume56,032
Average volume (3 months)66,333
Market cap$16.8M
Dividend yield--
Data as of 3:21pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)-106.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-52.01%
P/E ratio1.0
Price/Sales1.93
Price/Book1.63

Competitors

No competitors data available.

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$8.4M
Annual profit (last year)-$1.1M
Net profit margin-13.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Secretary
Andrew D. Rackear
Chief Financial &
Accounting Officer, VP-Finance
Richard L. Feinstein
Corporate headquarters
Cranford, New Jersey

Forecasts